CREST Update, June 2022

Features include:

  • Estimating potential cost-effectiveness of pancreatic cancer screening in patients with new-onset diabetes (CHERE)
  • Australasian Gastro-Intestinal Trials Group (AGITG)
  • Australasian Leukaemia and Lymphoma Group (ALLG)
  • Australia New Zealand Gynaecological Oncology Group (ANZGOG)
  • Cost-effectiveness of single vs multifraction SABR for pulmonary oligometastases: The SAFRON-II Trial (CHERE)
  • Australian & New Zealand Urogenital and Prostate (ANZUP)
  • Breast Cancer Trials (BCT)
  • Cancer Quality of Life Expert Service Team (CQUEST)
  • Cancer Symptom Trials (CST)
  • QUOKKA Research Program: Quality of life in kids, key evidence to strengthen decisions in Australia
  • CREST Health Economics Workshop
  • CREST Monthly Drop-In Health Economics Clinics

Download newsletter (PDF 2.1MB)

Share
Share this on LinkedIn
Back to CREST News
Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.